Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Zerr

Showing results (71-80 of 358) with videos related to

Pageof 36
Sort By:
Expert Review of Anti-Infective Therapy|August 7, 2007
Therapeutic approaches for prion disordersHeike Ludewigs, Chantal Zuber, Karen Vana, et al.
Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|January 10, 2002
[Course of anxiety, depression, and quality of life in relatives of patients with Creutzfeldt-Jakob-Disease]Christian Riedemann, Inga Zerr, Stefan Kropp, et al.
Journal of Neurology|July 24, 2013
Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysisLisa Kaerst, Andre Kuhlmann, Dirk Wedekind, et al.
Prion|February 20, 2014
Plasma prion protein concentration and progression of Alzheimer diseaseChristian Schmidt, Harry Becker, Christoph Peter, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 8, 2018
Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson's disease dementiaKarin Gmitterová, Joanna Gawinecka, Franc Llorens, et al.
Environmental Monitoring and Assessment|July 13, 2019
Cadmium induces GAPDH- and- MDH mediated delayed cell aging and dysfunction in Candida tropicalis 3AerZaman Khan, Muhammad Atif Nisar, Saima Muzammil, et al.
Neuroscience Letters|November 9, 2004
Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severityJens Weise, Olaf Crome, Raoul Sandau, et al.
Nature Reviews. Neurology|December 19, 2012
Immunotherapy in prion diseaseYvonne Roettger, Yansheng Du, Michael Bacher, et al.
Molecular Neurobiology|February 12, 2018
Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative DiseasesAnna Villar-Piqué, Matthias Schmitz, Niccolò Candelise, et al.
Gene|August 8, 2006
Polymorphic microsatellite sites in the PRNP region point to excess of homozygotes in Creutzfeldt-Jakob disease patientsHermann Geldermann, Heinz Bartenschlager, Siegfried Preuss, et al.
Pageof 36

Showing results (71-80 of 358) with videos related to

Sort By:
Pageof 36
Expert Review of Anti-Infective Therapy|August 7, 2007
Therapeutic approaches for prion disordersHeike Ludewigs, Chantal Zuber, Karen Vana, et al.
Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|January 10, 2002
[Course of anxiety, depression, and quality of life in relatives of patients with Creutzfeldt-Jakob-Disease]Christian Riedemann, Inga Zerr, Stefan Kropp, et al.
Journal of Neurology|July 24, 2013
Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysisLisa Kaerst, Andre Kuhlmann, Dirk Wedekind, et al.
Prion|February 20, 2014
Plasma prion protein concentration and progression of Alzheimer diseaseChristian Schmidt, Harry Becker, Christoph Peter, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 8, 2018
Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson's disease dementiaKarin Gmitterová, Joanna Gawinecka, Franc Llorens, et al.
Environmental Monitoring and Assessment|July 13, 2019
Cadmium induces GAPDH- and- MDH mediated delayed cell aging and dysfunction in Candida tropicalis 3AerZaman Khan, Muhammad Atif Nisar, Saima Muzammil, et al.
Neuroscience Letters|November 9, 2004
Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severityJens Weise, Olaf Crome, Raoul Sandau, et al.
Nature Reviews. Neurology|December 19, 2012
Immunotherapy in prion diseaseYvonne Roettger, Yansheng Du, Michael Bacher, et al.
Molecular Neurobiology|February 12, 2018
Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative DiseasesAnna Villar-Piqué, Matthias Schmitz, Niccolò Candelise, et al.
Gene|August 8, 2006
Polymorphic microsatellite sites in the PRNP region point to excess of homozygotes in Creutzfeldt-Jakob disease patientsHermann Geldermann, Heinz Bartenschlager, Siegfried Preuss, et al.
Pageof 36